Cargando…

Detection and correlation analysis of serum cytokines in non-small-cell lung cancer patients with bone and non-bone metastases

OBJECTIVE: To detect and analyze 13 cytokines that may be related to bone metastasis in the serum of non-small-cell lung cancer (NSCLC) patients with bone metastases and NSCLC patients with non-bone metastases. PATIENTS AND METHODS: The Luminex LiquiChip system was used to detect the concentration o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yingjia, Ai, Xinghao, Shen, Shengping, Gu, Linping, Lu, Shun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542409/ https://www.ncbi.nlm.nih.gov/pubmed/26316721 http://dx.doi.org/10.2147/PPA.S86605

Ejemplares similares

NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10
por: Sun, Yingjia, et al.
Publicado: (2015)

Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway
por: Ai, Xinghao, et al.
Publicado: (2018)

Tagrisso incremental therapy in a case of meningeal metastasis of lung cancer with EGFR mutation: a case report
por: Sun, Yingjia, et al.
Publicado: (2022)

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases
por: Daniele, Santini, et al.
Publicado: (2015)

Corrigendum: Natural History of Non-Small-Cell Lung Cancer with Bone Metastases
por: Santini, Daniele, et al.
Publicado: (2016)

Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
por: Landi, Lorenza, et al.
Publicado: (2019)

Bone metastases in non-small cell lung cancer: a narrative review
por: Knapp, Brendan J., et al.
Publicado: (2022)

Durable Response to the Combination of Atezolizumab With Platinum-Based Chemotherapy in an Untreated Non-Smoking Lung Adenocarcinoma Patient With BRAF V600E Mutation: A Case Report
por: Niu, Xiaomin, et al.
Publicado: (2021)

Serum dickkopf-1 as a clinical and prognostic factor in non-small cell lung cancer patients with bone metastases
por: Qiao, Rong, et al.
Publicado: (2017)

Can clinical factors be determinants of bone metastases in non-small cell lung cancer?
por: Ursavas, Ahmet, et al.
Publicado: (2007)

Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer
por: Shen, Jie, et al.
Publicado: (2023)

Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?
por: Deberne, Mélanie, et al.
Publicado: (2014)

BMP2 signalling activation enhances bone metastases of non‐small cell lung cancer
por: Huang, Fei, et al.
Publicado: (2020)

Bone decalcification to assess programmed cell death ligand 1 expression in bone metastases of non-small cell lung cancers
por: Pontarollo, Guillaume, et al.
Publicado: (2020)

An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer
por: Qi, Yuwen, et al.
Publicado: (2023)

Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer
por: Wu, Xiao-Tian, et al.
Publicado: (2020)

Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer
por: Zhou, Zhen, et al.
Publicado: (2012)

Diagnostic and prognostic validity of serum bone turnover markers in bone metastatic non-small cell lung cancer patients
por: Wang, Zhiyu, et al.
Publicado: (2015)

A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone Metastases
por: Chen, Yu-Mu, et al.
Publicado: (2016)

Association of RANKL and EGFR gene expression with bone metastases in patients with metastatic non-small cell lung cancer
por: Brouns, Anita J.W.M., et al.
Publicado: (2023)

Monoclonal antibodies in the detection of bone marrow metastases in small cell lung cancer.
por: Skov, B. G., et al.
Publicado: (1992)

Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer
por: Yang, Xiao-Rong, et al.
Publicado: (2020)

Case Report: SAPHO Syndrome Mimicking Bone Metastases During Treatment With Pembrolizumab for Non-small Cell Lung Cancer
por: Kubo, Yuko, et al.
Publicado: (2021)

The risk factors of bone metastases in patients with lung cancer
por: Zhou, Yang, et al.
Publicado: (2017)

Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective study
por: Qiang, Huiping, et al.
Publicado: (2022)

Adverse impact of bone metastases on clinical outcomes of patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors
por: Li, Xing, et al.
Publicado: (2020)

The relationship between different subtypes of KRAS and PD-L1 & tumor mutation burden (TMB) based on next-generation sequencing (NGS) detection in Chinese lung cancer patients
por: Yang, Ying, et al.
Publicado: (2022)

Serum total periostin is an independent marker of overall survival in bone metastases of lung adenocarcinoma
por: Massy, E, et al.
Publicado: (2021)

Serum miRNAs associated with tumor-promoting cytokines in non-small cell lung cancer
por: Chaniad, Pichitpon, et al.
Publicado: (2020)

Bone marrow metastases in small cell lung cancer: detection with magnetic resonance imaging and monoclonal antibodies.
por: Trillet, V., et al.
Publicado: (1989)

An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients
por: Gu, Linping, et al.
Publicado: (2021)

Serum microRNA-365 suppresses non-small-cell lung cancer metastasis and invasion in patients with bone metastasis of lung cancer
por: Liu, Yanyan, et al.
Publicado: (2020)

The Role of Post-Operative Radiotherapy for Non-Spine Bone Metastases (NSBMs)
por: Ramadan, Sherif, et al.
Publicado: (2023)

Clinical outcome for small cell lung cancer patients with bone metastases at the time of diagnosis
por: Gong, Linlin, et al.
Publicado: (2019)

Development of fever following first administration of zoledronate as a prognostic factor in advanced non-small cell lung cancer patients with bone metastases
por: Izumi, Hiroki, et al.
Publicado: (2017)

An Artificial Intelligence Model for Predicting 1-Year Survival of Bone Metastases in Non-Small-Cell Lung Cancer Patients Based on XGBoost Algorithm
por: Huang, Zhangheng, et al.
Publicado: (2020)

Multiple osteolytic bone and lung metastases from prostate cancer including small cell carcinoma with marked increases in CEA and Pro-GRP
por: Okamura, Shun, et al.
Publicado: (2019)

The Management of Brain Metastases in Non-Small Cell Lung Cancer
por: Owen, Scott, et al.
Publicado: (2014)

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma
por: Rybarczyk-Kasiuchnicz, Agnieszka, et al.
Publicado: (2021)

Soft tissue metastases of non-small cell lung cancer
por: Tiresse, Nabil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_irqu9avdr5rq30mqbknt798ef0